Pale islands in medulloblastoma consist of differentiated cells with low growth potential

Pathology International

Volumn 47, Issue 1, 1997, Pages 25-30

  Iijima, Misa ^a   Nakazato, Yoichi ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

differentiation; growth potential; Ki 67; medulloblastoma; pale island; proliferating cell nuclear antigen

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; EMBRYO DEVELOPMENT; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; MALE; MEDULLOBLASTOMA; PRIORITY JOURNAL;

EID: 0031015758     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.1997.tb04431.x     Document Type: Article

References (25)

1. Bailey P, Cushing H. Medulloblastoma cerebelli: A common type of midcerebellar glioma of childhood. Arch. Neurol. Psychiatry 1925; 14: 192-224.
2. Burger PC, Grahmann FC, Bliestle A, Kleihues P. Differentiation in the medulloblastoma: A histological and immunohistochemical study. Acta Neuropathol. 1987; 73: 115-123.
3. Katsetos CD, Liu HM, Zacks SI. Immunohistochemical and ultrastructural observations on Homer Wright (neuroblastic) rosettes and the 'pale islands' of human cerebellar medulloblastomas. Hum. Pathol. 1988; 19: 1219-1227.
4. Katsetos CD, Herman MH, Frankfurter A et al. Cerebellar desmoplastic medulloblastomas: A further immunohistochemical characterization of reticulin-free pale islands. Arch. Pathol. Lab. Med. 1989; 113: 1019-1029.
5. Molenaar WM, Jansson DS, Gould VE et al. Molecular markers of primitive neuroectodermal tumors and other pediatric central nervous system tumors: Monoclonal antibodies to neuronal and glial antigen distinguish subsets of primitive neuroectodermal tumors. Lab. Invest. 1989; 61: 635-643.
6. Maraziotis T, Perentes E, Karamitopoulou E et al. Neuron-associated class III β-tubulin isotype, retinal S-antigen, synaptophysin, and glial fibrillary acidic protein in human medulloblastomas: A clinicopathological analysis of 36 cases. Acta Neuropathol. 1992; 84: 355-363.
7. Rubinstein LJ, Northfield DWC. The medulloblastoma and the so-called 'arachnoidal cerebellar sarcoma': A critical re-examination of a nosological problem. Brain 1964; 87: 379-412.
8. Katsetos CD, Krishna L, Frankfurter A et al. A cytomorphological scheme of differentiating neuronal phenotypes in cerebellar medulloblastomas based on immunolocalizaton of class III β-tubulin isotype (β III) and proliferating cell nuclear antigen (PCNA)/cyclin. Clin. Neuropathol. 1995; 14: 72-80.
9. Herpers MJ, Budka H. Primitive neuroectodermal tumors including the medulloblastoma: Glial differentiation signaled by immunoreactivity for GFAP is restricted to the pure desmoplastic medulloblastoma ('arachnoidal sarcoma of the cerebellum'). Clin. Neuropathol. 1985; 4: 12-18.
10. Nakazato Y, Sasaki A, Hirato J et al. Immunohistochemical localization of neurofilament protein in neuronal degenerations. Acta Neuropathol. 1984; 64: 30-36.
11. Nakazato Y, Ishizeki J, Takahashi K et al. Localization of S-100 protein and glial fibrillary acidic protein-relate antigen in pleomorphic adenoma of the salivary glands. Lab. Invest. 1982; 46: 621-626.
12. Yamaguchi H. Studies on the immunohistochemical localization of S-100 and glial fibrillary acidic proteins in the rat nervous system and in human brain tumors. No To Shinkei 1980; 32: 1055-1064 (in Japanese).
13. Sasaki A, Nakanishi Y, Nakazato Y, Yamaguchi H. Application of lectin and B-lymphocyte-specific monoclonal antibodies for the demonstration of human microglia in formalin-fixed, paraffin-embedded brain tissue. Virchows Arch. A. Pathol. Anat. Histopathol. 1991; 419: 291-299.
14. Kleihues P, Burger PC, Schiethauer BW. Histological Typing of Tumours of the Central Nervous System, 2nd edn. Springer-Verlag, Berlin, 1993.
15. Yokoo H, Maeshima A, Sasaki A, Hirato J, Nakazato Y, Tamura M. Development of medullomyoblastoma from classical medulloblastoma following a long term latency. Brain Tumor Pathol. 1995; 12: 91-96.
16. Russell DS, Rubinstein LJ. Pathology of the Tumours of the Nervous System, 5th edn. Edward Arnold, London, 1989.
17. Choong PF, Akerman M, Willen H et al. Expression of proliferating cell nuclear antigen (PCNA) and Ki-67 in soft tissue sarcoma. Is prognostic significance histotype-specific? Acta Pathol. Microbiol. Scand. 1995; 103: 797-805.
18. Keshgegian AA, Cnaan A. Proliferation markers in breast carcinoma: Mitotic figure count, S-phase fraction, proliferating cell nuclear antigen, Ki-67 and MIB-1. Am. J. Clin. Pathol. 1995; 104: 42-49.
19. Sallinen PK, Haapasalo HK, Visakorpi T et al. Prognostication of astrocytoma patient survival by Ki-67 (MIB-1), PCNA, and S-phase fraction using archival paraffin-embedded samples. J. Pathol. 1994; 174: 275-282.
20. Pich A, Chiusa L, Comino A, Navone R. Cell proliferation indices, morphometry and DNA flow cytometry provide objective criteria for distinguishing low and high grade bladder carcinomas. Virchows Arch. 1994; 424: 143-148.
21. Pich A, Ponti R, Valente G et al. MIB-1, Ki 67, and PCNA scores and DNA flow cytometry in intermediate grade malignant lymphomas. J. Clin. Pathol. 1994; 47: 18-22.
22. Ito S, Hoshino T, Pardos MD, Edwards MSB. Cell kinetics of medulloblastomas. Cancer 1992; 70: 671-678.
23. Schiffer D, Cavalla P, Chio A et al. Tumor cell proliferation and apoptosis in medulloblastoma. Acta Neuropathol. 1994; 87: 362-370.
24. Schiffer D, Cavalla P, Migheli A et al. Apoptosis and cell proliferation in human neuroepithelial tumors. Neurosci. Lett. 1995; 195: 81-84.
25. Rosai J, ed. Ackerman's Surgical Pathology, 8th edn. Mosby, St Louis, 1996.